India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What is the specialty of Nepal? Nepal is a country of unique and special attributes that set it apart as a remarkable destination. Here are some key aspects that make Nepal special: Himalayan Majesty: Mount Everest: As the home of Mount Everest, the world's highest peak, Nepal stands as a symbol of majestic Himalayan beauty. The awe-inspiring landscapes and challenging trekking routes attract adventurers and nature enthusiasts from around the world. Cultural Diversity: Multicultural Tapestry: Nepal is a melting pot of cultures, languages, and ethnicities. The coexistence of various ethnic groups, such as the Gurung, Sherpa, Newar, and Tharu, creates a vibrant and diverse cultural tapestry. Spiritual Significance: Birthplace of Buddha: Lumbini, located in Nepal, is the birthplace of Siddhartha Gautama, who later became Buddha. This sacred site attracts pilgrims and spiritual seekers, adding a profound spiritual dimension to Nepal's identity. Living Heritage: Historic Cities: Th...